Other Inhibitors

Other Inhibitors groups bioactive small molecules whose targets fall outside the pathway categories of this catalogue. The compounds have not yet been assigned to target categories, so the range is broad and uneven. Streptozotocin, a glucosamine-nitrosourea compound used to induce experimental diabetes in rodents, sits beside the O-GlcNAcase inhibitor Thiamet G. Exherin is an N-cadherin antagonist, and AdipoRon is an agonist of adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2). Plant compounds such as the isoflavone daidzein are also included. Despite the category name, not every compound is an inhibitor, as the AdipoRon example shows. Compounds with a well-defined target are usually listed in the matching pathway or target category.

8 Items

  • TOK-8801
    Cat. No.
    A12288

    TOK-8801

    TOK-8801 is a synthesized dihydroimidazothiazole carboxamide and is under development as an immunomodulator.

    1 mg
    $265.00
    5 mg
    $715.00
    All 6 sizes
  • Parimifasor
    Cat. No.
    A12594

    Parimifasor

    Synonyms: LYC30937

    Parimifasor (LYC30937) is an immunomodulator, with anti-inflammatory activity.

    1 mg
    $35.00
    2 mg
    $50.00
    All 8 sizes
  • Plumbagin
    Cat. No.
    A15334

    Plumbagin

    Plumbagin, exhibits cytotoxicity in rodent models of carcinogenesis and carcinoma; has antifungal, antiviral, and antibacterial action.

    10 mg
    $25.00
    25 mg
    $45.00
    All 6 sizes
  • CPI-268456
    Cat. No.
    A15828

    CPI-268456

    CPI-268456 is a ligand of bromodomain-containing protein 4 (BRD4). It binds to BRD4 (IC50 =

    1 mg
    $65.00
    5 mg
    $135.00
    All 4 sizes
  • DPA-714
    Cat. No.
    A18585

    DPA-714

    Synonyms: J2.865.885K

    DPA-714 is a selective ligand for the translocator protein (TSPO) currently under evaluation for several clinical applications.It is also a PET tracer binding the TSPO receptor and highly expressed in myeloid cells.

    1 mg
    $70.00
    5 mg
    $180.00
    All 8 sizes
  • PZ-2891
    Cat. No.
    A18880

    PZ-2891

    PZ-2891 is an orally bioavailable, brain penetrant pantothenate kinase (PANK) modulator. PZ-2891 act as an orthosteric inhibitor at high concentrations and an allosteric activator at lower sub-saturating concentrations. PZ-2891 inhibits human pantothenate kinases PANK1β, PANK2, and PANK3 with IC50s of 40.2 nM, 0.7 nM and 1.3 nM, respectively.

    1 mg
    $25.00
    2 mg
    $40.00
    All 8 sizes
  • BTTAA
    Cat. No.
    A20374

    BTTAA

    BTTAA is a Cu(I)-stabilizing ligand, whch performs potently with ubiquitin Glu18AzF.

    1 mg
    $20.00
    5 mg
    $50.00
    All 6 sizes

8 Items

Added to your cart

View Cart Checkout

    Loading...